Back to top

Kymera is a new Outperform at RBC Capital Markets on lead asset

Kymera is a new Outperform at RBC Capital Markets on lead asset

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Kymera Therapeutics, Inc. (KYMR)

Regeneron Pharmaceuticals, Inc. (REGN)

Sanofi (SNY)